Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statement of Cash Flows

v3.25.0.1
Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating activities    
Net loss $ (11,330) $ (15,198)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation and amortization 1,608 1,698
Changes in provision for credit losses on accounts receivable 171 72
Common stock contribution to 401(k) plan 257 378
Stock-based compensation expense 1,373 1,858
(Gain) loss on revaluation of warrant liabilities (474) 133
Loss on modification of warrant 109 0
Unrealized loss (gain) on foreign currency transactions 965 (412)
Changes in operating assets and liabilities:    
Accounts receivable (1,967) (1,208)
Inventories 257 232
Prepaid expenses and other assets current and noncurrent 329 (158)
Accounts payable (288) (1,307)
Accrued, lease and other current and noncurrent liabilities (599) (134)
Deferred revenues (257) 1,992
Net cash used in operating activities (9,846) (12,054)
Investing activities    
Acquisition of property and equipment (37) (157)
Net cash used in investing activities (37) (157)
Financing activities    
Principal payments under note payable (1,250) (313)
Proceeds from issuance of common stock, net 9,019 661
Net cash provided by financing activities 7,769 348
Effect of exchange rate changes on cash (31) (24)
Net decrease in cash (2,145) (11,887)
Cash and restricted cash at beginning of the year 8,638 20,525
Cash and restricted cash at end of the year 6,493 8,638
Supplemental disclosure of cash flow activities    
Cash paid for interest 182 191
Cash paid for income taxes 8 45
Supplemental disclosure of non-cash activities    
Share issuance for common stock contribution to 401(k) plan 238 250
Transfer of inventory (from) to property and equipment 199 (82)
Initial recognition of (adjustment to) operating lease liabilities and right of use assets $ 180 $ (10)